Dissecting Mechanisms of Striatal Acetylcholine Transmission in the Vertebrate Brain
Project Number5F32MH131232-03
Contact PI/Project LeaderBEESON, KATHLEEN ALLISON
Awardee OrganizationHARVARD MEDICAL SCHOOL
Description
Abstract Text
PROJECT SUMMARY
Acetylcholine critically controls complex neurological functions through its modulation of brain circuits. In
contrast to the well-studied mechanisms of acetylcholine signaling at the neuromuscular junction, its
transmission modes and mechanisms in the vertebrate central nervous system are not well understood. In the
striatum, acetylcholine exerts rapid and powerful control over local dopaminergic activity. Together, these
neuromodulators regulate a variety of important behaviors, including motivation and reward-related learning.
Because acetylcholine is rapidly degraded after it is released in striatal tissues, the fidelity of acetylcholine to
dopamine signaling must involve either tight spatial relationships between release sites and receptors, and/or
fast transmission. However, neuromodulator signaling is classically modeled as occurring through volume
transmission, involving dispersed, non-specific release as opposed to synaptic, point-to-point signaling – a
concept that remains to be proven. Furthermore, the molecular mechanisms underlying striatal acetylcholine
signaling remain elusive. I hypothesize that sparse cholinergic terminals require molecular elements for highly
synchronous acetylcholine release. In this scenario, rapid and precise vesicle release could produce a
synchronous wave of high-concentration acetylcholine, which might allow even distant receptors to sense this
signal with potency.
To test this hypothesis, I propose to examine the morphological and molecular substrate of striatal
acetylcholine transmission in two aims. First, I will dissect the structure of acetylcholine to dopamine signaling
in the striatum, including the presence of secretory machinery in acetylcholine nerve terminals and their
apposition to acetylcholine receptors on dopamine axons, using superresolution microscopy. In a second aim, I
will functionally test whether acetylcholine release onto dopamine axons requires secretory proteins that are
predestined to generate fast and precise release, enabling phasic acetylcholine transmission. Additionally, I will
determine how this transmission mode impacts subsequent dopamine signaling. To do this, I will use genetic
tools paired with simultaneous imaging of fluorescent acetylcholine sensors and amperometric dopamine
measurements in striatal slices. Together, these findings will inform our fundamental understanding of
cholinergic to dopaminergic signaling in the striatum, including the identification of important genes that
regulate acetylcholine transmission. This molecular-level understanding will ultimately be important to better
understand brain function and disease.
Public Health Relevance Statement
PROJECT NARRATIVE
Neuromodulatory signaling in the brain provides critical control of a variety of complex behaviors including
motivation, reward-learning, and locomotion. Acetylcholine is an important modulatory transmitter in the
striatum, a brain structure that controls these functions. The proposed work aims to dissect the molecular
mechanisms of acetylcholine transmission in the striatum, with the overarching goal to better understand
neuromodulatory transmission in health and disease.
No Sub Projects information available for 5F32MH131232-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F32MH131232-03
Patents
No Patents information available for 5F32MH131232-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F32MH131232-03
Clinical Studies
No Clinical Studies information available for 5F32MH131232-03
News and More
Related News Releases
No news release information available for 5F32MH131232-03
History
No Historical information available for 5F32MH131232-03
Similar Projects
No Similar Projects information available for 5F32MH131232-03